Sale!

KIT Gene Leukemia Acute Myeloid Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “KIT Gene Leukemia Acute Myeloid Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the KIT gene that are often associated with acute myeloid leukemia (AML). This genetic test plays a critical role in the diagnosis and management of AML, as mutations in the KIT gene can influence the disease’s prognosis and guide treatment strategies. By analyzing a patient’s DNA sample, the test can detect specific genetic alterations in the KIT gene, helping healthcare providers to tailor more effective treatment plans based on the genetic makeup of the leukemia. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results.

Description

KIT Gene Leukemia acute myeloid Genetic Test

Components: KIT Gene Leukemia acute myeloid Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test gene KIT

Test Details:

The KIT gene is a gene that encodes for a protein called KIT receptor tyrosine kinase. This protein is involved in the regulation of cell growth and differentiation. Mutations in the KIT gene have been found to be associated with various types of cancer, including acute myeloid leukemia (AML).

Acute myeloid leukemia is a type of blood cancer that affects the bone marrow and blood cells. It is characterized by the rapid growth of abnormal white blood cells, which interfere with the production of normal blood cells.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of specific genes. It allows for the identification of mutations or changes in the DNA sequence that may be associated with diseases like leukemia.

In the context of AML, NGS genetic testing of the KIT gene can help identify specific mutations that may be driving the development or progression of the disease. This information can be used to guide treatment decisions, as certain mutations may respond better to targeted therapies.

Overall, the KIT gene NGS genetic test in acute myeloid leukemia aims to provide personalized and targeted treatment options based on the specific genetic profile of the tumor.

Test Name	KIT Gene Leukemia acute myeloid Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cancer
Doctor	Oncologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test gene KIT
Test Details	The KIT gene is a gene that encodes for a protein called KIT receptor tyrosine kinase. This protein is involved in the regulation of cell growth and differentiation. Mutations in the KIT gene have been found to be associated with various types of cancer, including acute myeloid leukemia (AML). Acute myeloid leukemia is a type of blood cancer that affects the bone marrow and blood cells. It is characterized by the rapid growth of abnormal white blood cells, which interfere with the production of normal blood cells. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of specific genes. It allows for the identification of mutations or changes in the DNA sequence that may be associated with diseases like leukemia. In the context of AML, NGS genetic testing of the KIT gene can help identify specific mutations that may be driving the development or progression of the disease. This information can be used to guide treatment decisions, as certain mutations may respond better to targeted therapies. Overall, the KIT gene NGS genetic test in acute myeloid leukemia aims to provide personalized and targeted treatment options based on the specific genetic profile of the tumor.